Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HPV-Driven Cervical Carcinogenesis: Genetic and Epigenetic Mechanisms and Diagnostic Approaches.

International journal of molecular sciences·2026
Same author

A Proteomics Resource Investigating Fibrosis: Proof-of-Concept for Identifying Novel Drug Candidates.

Proteomics·2025
Same author

m<sup>6</sup>A mRNA Methylation in Hematopoiesis: The Importance of Writing, Erasing, and Reading.

Cells·2025
Same author

Validated methods for isolation and qualification of mesenchymal stromal/stem cells from different sources.

Journal of translational medicine·2025
Same author

A Naturally Occurring Urinary Collagen Type I Alpha 1-Derived Peptide Inhibits Collagen Type I-Induced Endothelial Cell Migration at Physiological Concentrations.

International journal of molecular sciences·2025
Same author

Deciphering the Complexities of Adult Human Steady State and Stress-Induced Hematopoiesis: Progress and Challenges.

International journal of molecular sciences·2025

Related Experiment Video

Updated: May 21, 2026

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
08:24

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

Published on: February 28, 2017

Amniotic fluid and amniotic membrane stem cells: marker discovery.

Maria G Roubelakis1, Ourania Trohatou, Nicholas P Anagnou

  • 1Laboratory of Biology, University of Athens School of Medicine, 115 27 Athens, Greece.

Stem Cells International
|June 16, 2012
PubMed
Summary

Amniotic fluid and amniotic membrane stem cells show promise but require better markers for pure isolation. This review summarizes progress in identifying these crucial stem cell markers.

More Related Videos

In Vitro Culture of Epithelial Cells from Different Anatomical Regions of the Human Amniotic Membrane
10:00

In Vitro Culture of Epithelial Cells from Different Anatomical Regions of the Human Amniotic Membrane

Published on: November 28, 2019

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

Related Experiment Videos

Last Updated: May 21, 2026

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
08:24

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

Published on: February 28, 2017

In Vitro Culture of Epithelial Cells from Different Anatomical Regions of the Human Amniotic Membrane
10:00

In Vitro Culture of Epithelial Cells from Different Anatomical Regions of the Human Amniotic Membrane

Published on: November 28, 2019

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Amniotic fluid (AF) and amniotic membrane (AM) are sources of stem/progenitor cells.
  • These cells possess characteristics of both adult (mesenchymal) and embryonic stem cells.
  • Challenges include cellular heterogeneity and lack of specific markers for pure isolation.

Purpose of the Study:

  • To review recent advancements in marker discovery for AF and AM-derived stem cells.
  • To address the need for homogeneous stem cell populations for therapeutic applications.

Main Methods:

  • Analysis of transcriptomics, proteomics, and secretome data.
  • Focus on novel methodologies for marker identification.

Main Results:

  • Summarizes progress in identifying potential stem cell markers from fetal sources.
  • Highlights the heterogeneity and need for specific markers.

Conclusions:

  • Marker discovery is crucial for isolating pure stem cell populations from AF and AM.
  • Advancements in omics technologies are key to overcoming isolation challenges for therapeutic use.